Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Cutlass Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 14
Average round size
info
The average size of a deal this fund participated in
$20M
Portfolio companies 10
Rounds per year 0.67
Lead investments 0
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.29
Exits 8
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Medical Device
  • Health Care
  • Biotechnology
  • Therapeutics
  • Electronics
Summary

Cutlass Capital is the famous VC, which was founded in 2001. The fund was located in North America if to be more exact in United States. The main office of represented VC is situated in the Boston.

The typical case for the fund is to invest in rounds with 5-6 participants. Despite the Cutlass Capital, startups are often financed by Sutter Hill Ventures, MPM Capital, Frazier Healthcare Partners. The meaningful sponsors for the fund in investment in the same round are Sutter Hill Ventures, Maverick Ventures, Three Arch Partners. In the next rounds fund is usually obtained by Sutter Hill Ventures, Maverick Ventures, SV Health Investors.

The higher amount of exits for fund were in 2012. The common things for fund are deals in the range of 10 - 50 millions dollars. The high activity for fund was in 2008. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this VC is 9 percentage points more often commits exit comparing to other organizations. Opposing the other organizations, this Cutlass Capital works on 28 percentage points more the average amount of lead investments.

For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Therapeutics, Electronics. Among the various public portfolio startups of the fund, we may underline CardioKinetix, Evalve, Hemosphere The fund has exact preference in a number of founders of portfolio startups. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Cutlass Capital:
Typical Co-investors
Cutlass Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Cutlass Capital:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Bullrun Capital Inc British Columbia, Canada, Vancouver
Dazi Hemu Xiangchu Chuangye Touzi Guanli Youxian Gongsi Chengguan District, China, Lhasa
eEquity Stockholm, Stockholm County, Sweden
Gentry Venture Partners Chicago, Illinois, United States
Lunar Europe -
MUKC Fund I Mequon, United States, Wisconsin
Nord Holding Germany, Hanover, Niedersachsen
Optus Innov8 Australia, New South Wales, Sydney
Sanner Ventures Bensheim, Germany, Hessen
SVB Capital California, Palo Alto, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Hemosphere

Health Care
Medical Device
$9M07 Apr 2010 Georgia, United States

GI Dynamics

Biotechnology
Health Care
Medical Device
Therapeutics
$15M02 Mar 2009 Massachusetts, United States

CardioKinetix

Biotechnology
Health Care
Medical Device
$14M15 Jul 2008 California, United States

Xoft

Advanced Materials
Electronics
Medical Device
$20M05 Jan 2006 San Jose, California, United States

Xoft

Advanced Materials
Electronics
Medical Device
$10M26 May 2005 San Jose, California, United States

GI Dynamics

Biotechnology
Health Care
Medical Device
Therapeutics
$12M25 May 2004 Massachusetts, United States

TranS1

Biotechnology
Health Care
Life Science
Medical Device
mHealth
$12M12 May 2003 Denver, Colorado, United States

IntelliCare

Health Care
$10M23 Jun 2002 Portland, Maine, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Cutlass Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 14
Average round size 20M
Rounds per year 0.67
Peak activity year 2004
Lead investments 0
Follow on index 0.29
Exits 8
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Hemosphere

Health Care
Medical Device
$9M07 Apr 2010 Georgia, United States

GI Dynamics

Biotechnology
Health Care
Medical Device
Therapeutics
$15M02 Mar 2009 Massachusetts, United States

CardioKinetix

Biotechnology
Health Care
Medical Device
$14M15 Jul 2008 California, United States

Xoft

Advanced Materials
Electronics
Medical Device
$20M05 Jan 2006 San Jose, California, United States

Xoft

Advanced Materials
Electronics
Medical Device
$10M26 May 2005 San Jose, California, United States

GI Dynamics

Biotechnology
Health Care
Medical Device
Therapeutics
$12M25 May 2004 Massachusetts, United States

TranS1

Biotechnology
Health Care
Life Science
Medical Device
mHealth
$12M12 May 2003 Denver, Colorado, United States

IntelliCare

Health Care
$10M23 Jun 2002 Portland, Maine, United States
Crunchbase icon

Content report

The following text will be sent to our editors: